India  
NewsR.in
> >

J&J Ordered to Pay $4.69 Billion in Cancer Case

Duration: 01:17s - Published: < > Embed
News video: J&J Ordered to Pay $4.69 Billion in Cancer Case

J&J Ordered to Pay $4.69 Billion in Cancer Case The St.

Louis city court jury ordered the company to pay after 22 women said the baby powder gave them ovarian cancer.

The case is linked to more than 9,000 similar claims.

The women claimed the products contained asbestos which caused the cancer.

The plaintiff’s lawyer argued the company knew its products were contaminated and “rigged” tests.

J&J denied it and said they use the best labs for testing.

This is the sixth largest product-defect award in U.S. history.

Imerys SA was also sued since they provide the powder but settled the claim for $5 million.

Carol Goodrich, a J&J spokeswoman, said the verdict "was the product of a fundamentally unfair process.” The company plans to appeal the ruling..

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles

By Tina Bellon NEW YORK (Reuters) - Johnson & Johnson has vowed to appeal a $4.7 billion verdict...
Firstpost - Business


You Might Like


Recent related videos

J&J to pay $4.7 bln in cancer case [Video]J&J to pay $4.7 bln in cancer case

A Missouri jury ordered Johnson &amp; Johnson to pay a record $4.7 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to..

Rumble -

Nearly $4.7 Billion Awarded In Talcum Powder Case [Video]Nearly $4.7 Billion Awarded In Talcum Powder Case

A jury awarded nearly $4.7 billion in total damages to 22 women and their families after they claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer. CBS2's Dick..

CBS 2 New York -

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter